The disruption carries significant consequences for the healthcare supply chain, as it has blocked the company’s ability to process and ship orders to customers.
Boston Scientific operates 13 manufacturing facilities and serves medical providers in 127 countries, producing vital equipment such as pacemakers, heart stents, and catheters.
The company confirmed that the outage is affecting its global operations, though it has not yet determined the full financial scale of the damage.
Following the discovery, the company initiated incident response procedures and enlisted external cybersecurity specialists to contain the threat and investigate the breach.
According to a filing with the U.S.
Securities and Exchange Commission, there is currently no estimated timeline for when systems will be fully restored.
While the investigation continues, no threat actors have publicly claimed responsibility, and the company has not yet confirmed if any sensitive data was compromised.